Rapport Therapeutics Bolsa (NASDAQ: RAPP)

Rapport Therapeutics (NASDAQ:RAPP) Bolsa

Rapport Therapeutics

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Sportsman'sSaratoga,Springs,,Utah,,Usa,-,Nov,30,,2024:,Sportsman's,Warehouse

AEHL

AGMH

BIAF

DGLY

GRFS

NCNO

NMAX

QUAD

RAPP

RSLS

SAMG

SBFM

SPWH

STSS

SYRA

Sportsman&#39;s Warehouse sorprende con ingresos y ganancias inesperadas: conoce las cifras que hicieron subir sus acciones.

Acciones de Sportsman&#39;s Warehouse (SPWH) se disparan un 39%; Aquí están 20 acciones moviéndose en premercado

GameStop Corp.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BHIL

BSGM

CISO

CLEU

GDHG

HUMA

IMTE

NYXH

ORKA

PTPI

SURG

THTX

TXMD

WINT

ZYBT

El premercado de hoy revela fuertes movimientos bursátiles tras informes financieros y aprobaciones clave en sectores críticos.

Las acciones de GameStop (GME) suben alrededor del 13%; Aquí están 20 acciones que se mueven en el premercado

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics Inc

Insider Trades

Walmart Form4 Filing Shows Walton Family Holdings Trust Sold 378,639 Shares At An Average Price Of $97.52/Share

CBRE Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CBRE#NYSE">CBRE</a>) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.25%. Currently, CBRE Group has a market capitalization of $41.55 billion. 
Buying $1000 In CBRE: If an investor had bought $1000 of CBRE stock 5 years ago, it would be worth $3,150.54 today based on a price of $139.38 for CBRE at the time of writing.
<h3>CBRE Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751059848_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CBRE

Here's How Much $1000 Invested In CBRE Group 5 Years Ago Would Be Worth Today

Stock Split

BIVI

BioVie To Implement 1-For-10 Reverse Stock Split, Effective July 7, 2025

Offerings

TAOP

Taoping Files For Mixed Shelf Of Upto $100M

TRNR

Interactive Strength  Files For Mixed Shelf Of Up To $250M

NCNA

NuCana Entered Into Sales Agreement Relating To Sale Of Adss Offered By Prospectus Supplement; May Offer And Sell ADSs Of Up To $100M From Time To Time

SIEB

Siebert Financial Entered Into Sales Agreement Relating To Sale Of Shares Of Common Stock Offered By Prospectus Supplement; May Offer, Sell Shares Of Common Stock Of Up To $50M From Time To Time

US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) has outperformed the market over the past 5 years by 16.61% on an annualized basis producing an average annual return of 31.41%. Currently, US Foods Hldg has a market capitalization of $17.88 billion. 
Buying $1000 In USFD: If an investor had bought $1000 of USFD stock 5 years ago, it would be worth $3,867.37 today based on a price of $77.27 for USFD at the time of writing.
<h3>US Foods Hldg's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751058913_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

USFD

Here's How Much $1000 Invested In US Foods Hldg 5 Years Ago Would Be Worth Today

Air T (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRT#NASDAQ">AIRT</a>) reported quarterly losses of $(2.55) per share. This is a 325 percent decrease over losses of $(0.60) per share from the same period last year. The company reported $66.315 million in sales this quarter. This is a 8.76 percent decrease over sales of $72.680 million the same period last year.

Earnings

AIRT

Air T Q4 EPS $(2.55) Down From $(0.60) YoY, Sales $66.315M Down From $72.680M YoY

HOVR

New Horizon Aircraft Files For Offering Of Up To $16.5M Common Shares

General

GAME

Gamesquare Holdings Enters At-The-Market Sales Agreement With Thinkequity;  To Offer And Sell Shares Up To $9.25M

MBRX

Moleculin Biotech Receives Deficiency Letter From Nasdaq

<h3>Gainers</h3>
<ul>
<li>Golden Heaven Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDHG#NASDAQ">GDHG</a>) shares moved upwards by 13.5% to $1.26 during Friday's after-market session. The company's market cap stands at $18.3 million. </li>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) shares moved upwards by 13.4% to $0.28. </li>
<li>Boqii Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BQ#AMEX">BQ</a>) shares rose 11.94% to $2.25. The company's market cap stands at $6.1 million. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares moved upwards by 9.82% to $1.66. The company's market cap stands at $525.9 million. </li>
<li>Noodles (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDLS#NASDAQ">NDLS</a>) stock moved upwards by 6.99% to $0.65. The company's market cap stands at $32.8 million. </li>
<li>Naas Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) stock increased by 5.87% to $0.82. The company's market cap stands at $10.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Fitell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) stock decreased by 5.0% to $0.49 during Friday's after-market session. The company's market cap stands at $9.2 million. </li>
<li>Nova Lifestyle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVFY#NASDAQ">NVFY</a>) stock fell 4.29% to $1.34. The market value of their outstanding shares is at $19.7 million. </li>
<li>Rocky Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) shares declined by 4.26% to $21.4. The company's market cap stands at $163.6 million. </li>
<li>Live Ventures (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIVE#NASDAQ">LIVE</a>) shares fell 4.16% to $17.51. The market value of their outstanding shares is at $48.3 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares fell 3.82% to $6.55. The market value of their outstanding shares is at $3.6 million. </li>
<li>ECD Automotive Design (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECDA#NASDAQ">ECDA</a>) stock fell 3.16% to $0.27. The market value of their outstanding shares is at $8.9 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ECDA

FTEL

LIVE

NAAS

NDLS

NVFY

NWTN

PMNT

RCKY

VLCN

12 Consumer Discretionary Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Venus Concept (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) stock increased by 45.1% to $3.12 during Friday's after-market session. The market value of their outstanding shares is at $4.0 million. </li>
<li>Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) stock moved upwards by 20.0% to $1.5. The company's market cap stands at $79.8 million. </li>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) stock increased by 8.61% to $0.91. The market value of their outstanding shares is at $89.4 million. </li>
<li>Ovid Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OVID#NASDAQ">OVID</a>) shares increased by 8.01% to $0.33. The company's market cap stands at $24.3 million. </li>
<li>RenovoRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNXT#NASDAQ">RNXT</a>) stock moved upwards by 7.81% to $1.38. The market value of their outstanding shares is at $49.3 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares increased by 7.8% to $6.35. The company's market cap stands at $35.0 million. As per the press release, Q1 earnings came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sera Prognostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SERA#NASDAQ">SERA</a>) stock declined by 25.2% to $3.06 during Friday's after-market session. The company's market cap stands at $74.5 million. </li>
<li>Odysight ai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODYS#NASDAQ">ODYS</a>) shares decreased by 18.55% to $5.71. The market value of their outstanding shares is at $81.0 million. </li>
<li>Inhibikase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) shares declined by 16.05% to $1.36. The company's market cap stands at $122.6 million. </li>
<li>Autonomix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) stock fell 15.43% to $1.7. The company's market cap stands at $3.4 million. </li>
<li>Oragenics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#AMEX">OGEN</a>) stock decreased by 12.1% to $3.56. The market value of their outstanding shares is at $2.4 million. </li>
<li>Synaptogenix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPX#NASDAQ">SNPX</a>) shares declined by 7.2% to $5.61. The company's market cap stands at $6.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMIX

ODYS

OGEN

OVID

PLRX

RNXT

SERA

SNPX

VERO

VNRX

XCUR

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>MingZhu Logistics Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) stock moved upwards by 6.8% to $1.1 during Friday's after-market session. The market value of their outstanding shares is at $85.1 million. </li>
<li>INLIF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INLF#NASDAQ">INLF</a>) shares increased by 6.19% to $1.2. The market value of their outstanding shares is at $17.8 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) stock moved upwards by 5.96% to $0.26. The company's market cap stands at $71.8 million. </li>
<li>FiscalNote Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) stock increased by 5.96% to $0.51. The company's market cap stands at $84.1 million. </li>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock increased by 5.64% to $1.49. The market value of their outstanding shares is at $15.6 million. </li>
<li>Globavend Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares increased by 5.56% to $0.14. The market value of their outstanding shares is at $2.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Phoenix Asia Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHOE#NASDAQ">PHOE</a>) shares declined by 8.6% to $6.88 during Friday's after-market session. The company's market cap stands at $160.2 million. </li>
<li>WF International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WXM#NASDAQ">WXM</a>) shares decreased by 5.11% to $2.6. The market value of their outstanding shares is at $17.4 million. </li>
<li>WF Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WFF#NASDAQ">WFF</a>) stock decreased by 5.02% to $3.79. The market value of their outstanding shares is at $167.2 million. </li>
<li>Concorde Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIGL#NASDAQ">CIGL</a>) shares declined by 4.95% to $9.22. The market value of their outstanding shares is at $181.7 million. </li>
<li>Byrna Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>) stock decreased by 4.91% to $30.02. The market value of their outstanding shares is at $701.4 million. </li>
<li>JVSPAC Acquisition (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JVSA#NASDAQ">JVSA</a>) shares decreased by 4.87% to $10.36. The market value of their outstanding shares is at $72.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BYRN

CIGL

HKPD

INLF

JVSA

LNZA

NOTE

PHOE

YGMZ

12 Industrials Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Mobilicom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOB#NASDAQ">MOB</a>) stock moved upwards by 9.3% to $2.71 during Friday's after-market session. The company's market cap stands at $21.2 million. </li>
<li>Wetouch Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WETH#NASDAQ">WETH</a>) shares increased by 7.97% to $1.07. The company's market cap stands at $10.9 million. </li>
<li>Mawson Infra Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIGI#NASDAQ">MIGI</a>) shares rose 7.62% to $0.42. The company's market cap stands at $8.7 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock moved upwards by 6.09% to $0.95. The market value of their outstanding shares is at $18.4 million. </li>
<li>PicoCELA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCLA#NASDAQ">PCLA</a>) stock increased by 5.63% to $1.5. The market value of their outstanding shares is at $46.9 million. </li>
<li>ReAlpha Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>) stock rose 5.09% to $0.33. The company's market cap stands at $17.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Saverone 2014 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) stock decreased by 9.4% to $2.88 during Friday's after-market session. The market value of their outstanding shares is at $1.0 million. </li>
<li>Ostin Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OST#NASDAQ">OST</a>) stock declined by 7.13% to $0.32. The market value of their outstanding shares is at $59.0 million. </li>
<li>Youxin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YAAS#NASDAQ">YAAS</a>) stock declined by 6.67% to $4.2. The company's market cap stands at $124.8 million. </li>
<li>ClearOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRO#NASDAQ">CLRO</a>) stock declined by 5.15% to $5.35. The company's market cap stands at $9.0 million. </li>
<li>Cheetah Mobile (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMCM#NYSE">CMCM</a>) shares declined by 4.35% to $4.4. The company's market cap stands at $134.4 million. </li>
<li>Rackspace Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXT#NASDAQ">RXT</a>) stock decreased by 4.25% to $1.24. The market value of their outstanding shares is at $301.4 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRE

CLRO

CMCM

LIDR

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

PCLA

SVRE

WETH

YAAS

12 Information Technology Stocks Moving In Friday's After-Market Session

Boqii Holding Limited ("Boqii" or the "Company") (NYSE American:&nbsp;BQ) today announced that it will terminate the Deposit Agreement dated September 29, 2020 (the "Termination"), among the Company, The Bank of New York Mellon (the "Depositary"), and the owners and holders of American depositary shares (the "ADSs") from time to time in the near future, which was approved by its shareholders on June 26, 2025. In conjunction with this Termination, the Company will effect a reverse stock split, consolidating every 160 ordinary shares into one new ordinary share (the "Reverse Split").
In connection with the termination of the Company's ADR facility and Reverse Split, the Company plans to list its Class A ordinary shares for trading on NYSE American LLC ("AMEX") in substitution for the ADSs (the "Substitution Listing"). The Company expects that, upon the effectiveness of the Substitution Listing, its ADSs will cease to be listed on AMEX while the Class A ordinary shares represented by the ADSs will trade on AMEX under the symbol of "BQ." The Company has appointed VStock Transfer, LLC as its transfer agent in the United States for its ordinary shares. The new Committee on Uniform Securities Identification Procedures (CUSIP) for the Company's Class A ordinary shares number is G1311F119.

Boqii To Terminate ADR Program, Implement 160-For-1 Reverse Stock Split, And List Class A Ordinary Shares Directly On NYSE American

In the current session, the stock is trading at $106.00, after a 0.60% increase. Over the past month, State Street Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) stock increased by 10.10%, and in the past year, by 44.10%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1751058019_0.png" alt="Past Year Chart" />

<h3>Comparing State Street P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 35.38 in the Capital Markets industry, State Street Inc. has a lower P/E ratio of 11.87. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1751058019_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

P/E Ratio Insights for State Street

EMCOR Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EME#NYSE">EME</a>) has outperformed the market over the past 10 years by 15.76% on an annualized basis producing an average annual return of 27.24%. Currently, EMCOR Group has a market capitalization of $23.91 billion. 
Buying $1000 In EME: If an investor had bought $1000 of EME stock 10 years ago, it would be worth $11,011.00 today based on a price of $530.62 for EME at the time of writing.
<h3>EMCOR Group's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751058014_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning EMCOR Group Stock In The Last 10 Years

<a href="https://www.globenewswire.com/Tracker?data=H9aHvFQXoefUFYRxjIHMf3bY-ZDzH-RfzLDA2A-u3_VBST2aGMuvffZuvJMDrqNRNs45puqoUZCD69Ui0QyDXA==">Gemini</a> today listed its first tokenized U.S. stock, MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), powered by Dinari, the leading provider of tokenized U.S. public securities. The launch opens trading to customers in Europe and Asia-Pacific and kicks off a series of public-equity offerings that pair Dinari's tokenization-on-demand infrastructure with Gemini's regulated platform.
Gemini has a history of debuting regulated, first-to-market products, from insured custody to the industry's earliest SOC-certified exchange. Adding tokenized U.S. equities is the next step in that roadmap, layering real-world stocks onto a venue that already supports more than 80 digital assets and safeguards roughly $8 billion in customer holdings.
Through Dinari's platform, Gemini users can now trade fully backed MicroStrategy (MSTR) dSharesTM alongside crypto. Dinari's rollout of 24/5 primary market trading to coincide with the launch offers customers traditional-market liquidity and transparent pricing, while Gemini's infrastructure offers seamless DeFi interoperability while maintaining a focus on compliance.
The rollout of the tokenized equity offering began for European and Asia-Pacific customers today and looks to extend to additional regions, including the United States, over the coming months.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

MSTR

Gemini Launches Tokenized MicroStrategy Stock Trading For Europe And Asia-Pacific Via Dinari, Expanding Regulated Access To U.S. Equities On Crypto Platform

Health Care

Press Releases

CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS Disorders

Rapport Therapeutics to Participate in Upcoming Investor Conferences

Management

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting

Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business Update

Rapport Therapeutics to Host 2025 Investor and Analyst Day

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

Comments

Rapport Therapeutics

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL